A crucial step in handling the sale of genetic data from over 15 million 23andMe customers now rests largely in the hands of a law professor.
The May 19 announcement that
In a report due before June 10, he’ll recommend to the judge whether—and how—the sale of data should take place, highlight any necessary changes to mitigate consumer harm, and evaluate Regeneron’s ...
